427 related articles for article (PubMed ID: 35276950)
1. The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review.
Diotallevi F; Campanati A; Martina E; Radi G; Paolinelli M; Marani A; Molinelli E; Candelora M; Taus M; Galeazzi T; Nicolai A; Offidani A
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276950
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
[TBL] [Abstract][Full Text] [Related]
3. The role of nutrition, food allergies, and gut dysbiosis in immune-mediated inflammatory skin disease: a narrative review.
Bourkas AN; Lara-Corrales I
Curr Opin Pediatr; 2023 Aug; 35(4):452-459. PubMed ID: 37335275
[TBL] [Abstract][Full Text] [Related]
4. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases.
Schneeweiss MC; Kim SC; Wyss R; Jin Y; Chin K; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S
JAMA Dermatol; 2021 Jul; 157(7):805-816. PubMed ID: 34037662
[TBL] [Abstract][Full Text] [Related]
6. Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.
Aguwa C; Enwereji N; Santiago S; Hine A; Kels GG; McGee J; Lu J
Clin Dermatol; 2023; 41(5):640-649. PubMed ID: 37816413
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric and psychologic aspects of chronic skin diseases.
Christensen RE; Jafferany M
Clin Dermatol; 2023; 41(1):75-81. PubMed ID: 36878453
[TBL] [Abstract][Full Text] [Related]
8. A Review of Skin Disease in Schizophrenia.
McPhie ML; Bridgman AC; Kirchhof MG
Dermatology; 2021; 237(2):248-261. PubMed ID: 32759610
[TBL] [Abstract][Full Text] [Related]
9. Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases.
Czarnowicki T; He H; Leonard A; Kim HJ; Kameyama N; Pavel AB; Li R; Estrada Y; Wen HC; Kimmel GW; Kim HJ; Chima M; Lebwohl M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jun; 143(6):2095-2107. PubMed ID: 30576756
[TBL] [Abstract][Full Text] [Related]
10. Topical Janus kinase inhibitors: A review of applications in dermatology.
Hosking AM; Juhasz M; Mesinkovska NA
J Am Acad Dermatol; 2018 Sep; 79(3):535-544. PubMed ID: 29673776
[TBL] [Abstract][Full Text] [Related]
11. JAK-inhibitors in dermatology: current evidence and future applications.
Ciechanowicz P; Rakowska A; Sikora M; Rudnicka L
J Dermatolog Treat; 2019 Nov; 30(7):648-658. PubMed ID: 30433838
[TBL] [Abstract][Full Text] [Related]
12. Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
Migayron L; Bordes S; Closs B; Seneschal J; Boniface K
Front Immunol; 2024; 15():1405215. PubMed ID: 38868763
[TBL] [Abstract][Full Text] [Related]
13. The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review.
Dopytalska K; Czaplicka A; Szymańska E; Walecka I
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298095
[TBL] [Abstract][Full Text] [Related]
14. Skin diseases associated with atopic dermatitis.
Fenner J; Silverberg NB
Clin Dermatol; 2018; 36(5):631-640. PubMed ID: 30217275
[TBL] [Abstract][Full Text] [Related]
15. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata.
Ghajarzadeh M; Ghiasi M; Kheirkhah S
Acta Med Iran; 2012; 50(7):511-5. PubMed ID: 22930385
[TBL] [Abstract][Full Text] [Related]
16. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study.
Richard MA; Corgibet F; Beylot-Barry M; Barbaud A; Bodemer C; Chaussade V; D'Incan M; Joly P; Leccia MT; Meurant JM; Petit A; Geffroy BR; Sei JF; Taieb C; Misery L; Ezzedine K
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1967-1971. PubMed ID: 29569785
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases.
Gibson F; Hanly A; Grbic N; Grunberg N; Wu M; Collard M; Alani RM
Clin Rev Allergy Immunol; 2022 Dec; 63(3):447-471. PubMed ID: 36346551
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
Patsatsi A; Kyriakou A
Clin Dermatol; 2021; 39(1):52-55. PubMed ID: 33972053
[TBL] [Abstract][Full Text] [Related]
19. Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology.
Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
Curr Med Chem; 2017 May; 24(11):1158-1167. PubMed ID: 28088907
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.
Kim M; Choi KH; Hwang SW; Lee YB; Park HJ; Bae JM
J Am Acad Dermatol; 2017 Jan; 76(1):40-48. PubMed ID: 27793451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
